Buscar resultados de ensayos clínicos
Rhabdomyosarcoma, Alveolar - 10 Studies Found
Estado | Estudiar |
Recruiting |
Nombre del estudio: Insulin-like Growth Factor 1 Receptor (IGF-1R) Antibody AMG479 (Ganitumab) in Combination With the Src Family Kinase (SFK) Inhibitor Dasatinib in People With Embryonal and Alveolar Rhabdomyosarcoma Condición:
|
Recruiting |
Nombre del estudio: A Two-Part Study of TB-403 in Pediatric Subjects With Relapsed or Refractory Medulloblastoma Condición: Relapsed or Refractory Medulloblastoma (MB) (Part A: Also Include Neuroblastoma (NB), Ewing Sarcoma (ES) and Alveolar Rhabdomyosarcoma (ARMS)) Fecha: 2016-04-08 Intervenciones:
|
Suspended |
Nombre del estudio: Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma Condición:
|
Completed |
Nombre del estudio: Temozolomide, Cixutumumab, and Combination Chemotherapy in Treating Patients With Metastatic Rhabdomyosarcoma Condición:
Fecha: 2010-01-22 Intervenciones: |
Completed |
Nombre del estudio: Studying Protein Expression in Tissue Samples From Younger Patients With Rhabdomyosarcoma Condición:
Fecha: 2012-08-15 Intervenciones: Other: Laboratory Biomarker Analysis Correlative studies |
Completed |
Nombre del estudio: Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma Condición:
Fecha: 2010-10-15 Intervenciones: |
Recruiting |
Nombre del estudio: CREATE: Cross-tumoral Phase 2 With Crizotinib Condición:
|
Active, not recruiting |
Nombre del estudio: Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma Condición:
|
Active, not recruiting |
Nombre del estudio: Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features Condición:
Fecha: 2006-04-13 Intervenciones: Drug: Seneca Valley Virus (biological agent) Dose escalation (starting at 1 × 10^7 vp/kg), IV (in t |